Burning Mouth Syndrome Clinical Trial
Official title:
A Prospective Study on the Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine(TCM) and Western Medicine Based on TCM Syndrome Differentiation
This study is an open-label randomized controlled trial of the efficacy of the integration of Traditional Chinese medicine (TCM) and western medicine based on TCM syndrome differentiation. The hypothesis is (1) TCM model can identify the primary and secondary type burning mouth syndrome (BMS); (2) TCM model can identify BMS after treatment with western medicine; (3) There is a positive effect of TCM in treating BMS.
BMS patients will be classified into the primary type and secondary type according to the
patients' clinical histories and laboratory examinations. The secondary BMS only includes
nutritional deficiency, such as Vitamin B12, folate, iron, zinc. At first, the primary BMS
patients are treated with 0.5~1 mg clonazepam every day before sleep for 8 weeks. The
secondary BMS patients are treated with vitamin B12, folate, iron and zinc according to the
patient's nutritional deficiency status. Patients with no improvement or little improvement
after the first stage of Western medicine management will be arranged to receive traditional
Chinese medicine (TCM) therapy. All patients will receive the TCM model, including TCM
doctor, automatic tongue diagnostic system (ATDS), and body constitutional questionnaire
(BCQ), evaluations.
The results of this study are expected to understand whether adjuvant TCM treatment of BMS
can improve treatment efficacy. The investigators will understand whether the constitution
pattern may be a predictive indicator of efficacy for western BMS. The investigators will
find a diagnostic indicator for the TCM model and apply it to the assessment of the prognosis
of BMS patients.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04475614 -
Therapeutic Options for Treatment of Burning Mouth Syndrome
|
N/A | |
| Completed |
NCT00374673 -
Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders
|
Phase 3 | |
| Completed |
NCT02964728 -
Botulinum Toxin in Burning Mouth Syndrome
|
Phase 2 | |
| Completed |
NCT04535973 -
Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
|
||
| Recruiting |
NCT06040190 -
Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
|
Phase 4 | |
| Not yet recruiting |
NCT05059418 -
Burning Mouth Syndrome - New Diagnostic Criteria and Treatment
|
N/A | |
| Recruiting |
NCT01867151 -
Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome
|
N/A | |
| Completed |
NCT05872789 -
Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
|
N/A | |
| Completed |
NCT05871580 -
Effect to the Photobiomodulation in the Burning Mouth Syndrome
|
N/A | |
| Recruiting |
NCT05309070 -
The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome
|
N/A | |
| Completed |
NCT05399238 -
Thermography and Burning Mouth Syndrome
|
||
| Completed |
NCT02382029 -
Acupuncture Versus Clonazepam in Burning Mouth Syndrome
|
Phase 0 | |
| Completed |
NCT02580734 -
Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
|
N/A | |
| Recruiting |
NCT05819697 -
Reducing Patient Memory Recall in the Burning Mouth Patient Population
|
||
| Completed |
NCT02757612 -
Study Evaluating the Laser Diode Effect Burning Mouth Syndrome
|
N/A | |
| Completed |
NCT00862576 -
A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome
|
N/A | |
| Completed |
NCT00001524 -
Thalidomide to Treat Oral Lesions in HIV-Infected Patients
|
Phase 2 | |
| Recruiting |
NCT04481841 -
Head Yuanshi Dian Therapy in Burning Mouth Syndrome
|
Early Phase 1 | |
| Completed |
NCT02686359 -
Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN)
|
N/A | |
| Completed |
NCT05309681 -
Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome
|